BiotechTV

•

Kanal • 5 Sendungen

Biowissenschaften

Biowissenschaften

30.06.2025
Biowissenschaften

Biowissenschaften

25. März
Biowissenschaften

Biowissenschaften

2. Feb.
Biowissenschaften

Biowissenschaften

Zweiwöchentlich
Biowissenschaften

Biowissenschaften

5. März

23. MÄRZ

Episode 37: SR One's Simeon George

Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.

23. März

•

1 Std. 6 Min.
9. MÄRZ

Episode 36: Sofinnova Invetments' Jim Healy

He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.

9. März

•

1 Std. 2 Min.
08.05.2025

Munich based ITM Radiopharma is progressing towards a first NDA in the U.S. with a robust pipeline behind it - all the while making investments in isotope manufacturing that has slowed others

CEO Andrew Cavey describes how ITM has been investing to avoid the shortages others have experienced, and explains how the supply chain works for radiopharmaceuticals. He walks us through the science behind these medicines before highlighting ITM's pipeline.

08.05.2025

•

21 Min.
19. MÄRZ

From London: Syncona CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day

He talks about Syncona's listed fund, and clarifies the details of a return of capital strategy for some shareholders, and he describes the strategy of the firm's new private fund. Plus, how Syncona thinks about opportunities in life sciences today.

19. März

•

18 Min.
18. MÄRZ

Checking in with Menlo Ventures' Partner Greg Yap to get his take on the latest trends in AI in healthcare

He his take on topics such as how the Baby KJ news is allowing investors and companies to think about scaling bespoke therapies, how AI might start to impact the clinical trial side of our business, and why he sees pharma adoption of AI as being important.

18. März

•

18 Min.
11. JAN.

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

11. Jan.

•

1 Std. 15 Min.
9. FEB.

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

9. Feb.

•

1 Std. 7 Min.
22. JAN.

Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks

She discusses Arrivent Biopharma, Oruka Therapeutics, Jade Biosciences, Zura Bio, and Pavella Therapeutics.

22. Jan.

•

17 Min.
23. FEB.

Episode 35: INITIATE Ventures' Jessica Owens

Jessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.

23. Feb.

•

1 Std. 9 Min.
12. JAN.

SF Healthcare Week: Flagship Pioneering's Founder Noubar Afeyan shares his thoughts on the image of science in the United States today, biotech's roller coaster 2025, mRNA, AI, and more

He discusses the theme of his annual letter that was published today, "Choosing Science," and why it is important that our country continues to invest in basic research. Plus, his take on the M&A environment in biotech.

12. Jan.

•

18 Min.

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Kanal-Website

BiotechTV

Top-Sendungen

Episode 37: SR One's Simeon George

Episode 36: Sofinnova Invetments' Jim Healy

Munich based ITM Radiopharma is progressing towards a first NDA in the U.S. with a robust pipeline behind it - all the while making investments in isotope manufacturing that has slowed others

From London: Syncona CEO Chris Hollowood discusses the firm's public and private funds, and the state of investing in life sciences today from the firm's Capital Markets Day

Checking in with Menlo Ventures' Partner Greg Yap to get his take on the latest trends in AI in healthcare

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 34: General Atlantic's Brett Zbar

Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks

Episode 35: INITIATE Ventures' Jessica Owens

SF Healthcare Week: Flagship Pioneering's Founder Noubar Afeyan shares his thoughts on the image of science in the United States today, biotech's roller coaster 2025, mRNA, AI, and more

Info

BiotechTV

Top-Sendungen

Top-Folgen

Info